Style | Citing Format |
---|---|
MLA | Honarvar NM, et al.. "Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 2, 2021, pp. 365-373. |
APA | Honarvar NM, Soveid N, Abdolahi M, Djalali M, Hatami M, Karzar NH (2021). Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial. Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(2), 365-373. |
Chicago | Honarvar NM, Soveid N, Abdolahi M, Djalali M, Hatami M, Karzar NH. "Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial." Endocrine# Metabolic and Immune Disorders - Drug Targets 21, no. 2 (2021): 365-373. |
Harvard | Honarvar NM et al. (2021) 'Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial', Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(2), pp. 365-373. |
Vancouver | Honarvar NM, Soveid N, Abdolahi M, Djalali M, Hatami M, Karzar NH. Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2021;21(2):365-373. |
BibTex | @article{ author = {Honarvar NM and Soveid N and Abdolahi M and Djalali M and Hatami M and Karzar NH}, title = {Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {21}, number = {2}, pages = {365-373}, year = {2021} } |
RIS | TY - JOUR AU - Honarvar NM AU - Soveid N AU - Abdolahi M AU - Djalali M AU - Hatami M AU - Karzar NH TI - Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 21 IS - 2 SP - 365 EP - 373 PY - 2021 ER - |